According to Krystal Biotech's latest financial reports the company's current EPS (TTM) is -$5.43. In 2022 the company made an earnings per share (EPS) of -$5.51 a decrease over its 2021 EPS that were of -$3.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.43 | -1.45% |
2022 | -$5.51 | 76.04% |
2021 | -$3.13 | 84.12% |
2020 | -$1.70 | 39.34% |
2019 | -$1.22 | 25.77% |
2018 | -$0.97 | -39.3% |
2017 | -$1.60 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -59.85% | ๐บ๐ธ USA |